CombiMatrix Q4 Revenues Spike 18 Percent on Prenatal Array Testing Growth | GenomeWeb

NEW YORK (GenomeWeb News) – CombiMatrix today said that revenues in the fourth quarter jumped 18 percent year over year as revenues from core prenatal testing markets increased 57 percent.

For the three months ended Dec. 31, 2013, the Irvine, Calif.-based genetic testing laboratory saw revenues increase to $1.8 million from $1.5 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.